NCT04684641View on ClinicalTrials.gov

CYstic Fibrosis bacterioPHage Study at Yale (CYPHY)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

March 29, 2021

Primary Completion Date

May 26, 2023

Study Completion Date

June 22, 2023

Conditions
Cystic Fibrosis
Interventions
DRUG

Standard Dose YPT-01

Participants will be randomized to receive the standard dose of phage therapy YPT-01.

OTHER

Placebo

Participants will be randomized to receive the placebo.

Trial Locations (1)

06520

Yale New Haven Hospital, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT04684641 - CYstic Fibrosis bacterioPHage Study at Yale (CYPHY) | Biotech Hunter | Biotech Hunter